The global allergy immunotherapy market is anticipated to grow at a CAGR 8.2% during the forecast period. The factor such as increasing awareness of allergies in the patients is anticipated to propel the growth of the allergy immunotherapy industry. According to the World Allergy Organization, an increase in the pervasiveness of allergies has been witnessed and around 30% of the world population has allergic rhinitis. As per the Centers for Disease Control and Prevention (CDC), more than 8% of the adults in the US suffer from sinusitis and hay fever. The awareness created by these organizations, governments of different countries has sanctioned budget for the R&D of allergy immunotherapy as an effective cure. Thus, this factor has a positive impact on the growth of the allergy immunotherapy market during the forecast period.

Request a Free Sample of our Global Allergy Immunotherapy Market: https://www.omrglobal.com/request-sample/allergy-immunotherapy-market

The factor such as the growing prevalence of gastrointestinal diseases, rising investments, and funding in the field of life science research that boost the growth of the allergy immunotherapy market during the forecast period. Allergy immunotherapy is also known as hypo-sensitization. It is a type of medical treatment that allows for tackling various types of allergies. There has been significant growth in the various types of allergies across the globe. Pharmacotherapy is not enough to tackle and control the occurrence of these allergic disorders. Therefore, it is a major driving factor for the development of the allergy immunotherapy market. The use of these treatments enables in building up the tolerance level against the allergic substances and enables in altering the course of the disorders.

A full Report of Global Allergy Immunotherapy Market is Available at: https://www.omrglobal.com/industry-reports/allergy-immunotherapy-market

Global Allergy Immunotherapy Market Segmentation

By Type

• Allergic Rhinitis
• Allergic Asthma
• Food Allergy
• Drug Allergy
• Others

By Treatment

• Subcutaneous Immunotherapy
• Sublingual Immunotherapy
By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Regional Analysis

• North America
• US
• Canada
• Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Rest of the World

Company Profiles

• Aimmune Therapeutics, Inc.
• ALK-Abello A/S
• Allergopharma (A Division of Merck KGaA)
• Allergy Therapeutics PLC
• Biomay AG
• CircassiaPharmaceuticals PLC
• DBV Technologies S.A.
• Desentum Oy
• HAL Allergy Group
• Jubilant Life Sciences, Ltd.
• LetiPharma
• Merck KGaA
• Sandoz, Inc.
• Stallergenes GREER, Ltd.
• Torii Pharmaceutical Co, Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/allergy-immunotherapy-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 7803040404